ADVENT is a global medical education program by Sanofi and Regeneron. This website is intended for Healthcare Professionals based in the United Kingdom only. This platform contains product information. Adverse event reporting statement and prescribing information can be found at the bottom of the page.

Sign up to ADVENT

Do you already have an account? Log in

Create new account

Step 1 of 3

Country/region:

United KingdomChange country/region

Personal information

Title

First name

Last name

Medical License Number

This is just to verify that you really are a healthcare professional

Password

The password must have at least 8 characters, at least 1 digit(s), at least 1 lower case letter(s), at least 1 upper case letter(s), at least 1 non-alphanumeric character(s) such as as *, -, or #

Allow Sanofi to contact you by email with information about goods or services which may be of interest to you, including promotional information about our products. We may engage a third-party provider to send these emails on our behalf.

(optional)

For information about how Sanofi may process your personal data if you sign-up to receive email updates from Sanofi, please see Sanofi Privacy Notice here.

ADVENT is a global medical education program by Sanofi and Regeneron. This website is intended for Healthcare Professionals based in the United Kingdom only.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Sanofi drug safety department on Tel: 0800 0902 314. Alternatively, send via email to UK-drugsafety@sanofi.com.

This platform contains product information and you can find the link for the Prescribing Information below. 

Dermatology PI Asthma PI COPD PI CRSwNP PI

All Rights Reserved.
Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United KingdomChange country/region